SEMAGLUTIDE (Rybelsus®)
Clinical Indication
Type 2 diabetes
Date of classification
September 2020
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.